7248

    500259

    LYKALABS

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    LYKA LABS LTD Share Price Today

    LYKA LABS LTD. is currently trading at ₹60, down by ₹1.7 from the previous close. The stock touched an intraday high of ₹62.45 and a low of ₹59.90 during the latest trading session. Over the past one year, LYKA LABS LTD. has delivered a loss of 44.11%, while the stock has declined 15.51% in the last one month.

    LYKA LABS LTD performance

    Today’s low Today’s high
    ₹ 59.90 ₹ 62.45
    ₹ 60.00
    52 week low 52 week high
    ₹ 44.10 ₹ 121.44
    ₹ 60.00
    Open Price ₹ 61.19
    Prev. Close ₹ 61.71
    Volume (Shares) 16797.00
    Total traded value ₹ 10.07
    Upper Circuit ₹ 64.79
    Lower Circuit ₹ 58.63
    info

    Investment Returns

    Over 1 Month -15.51% Over 3 Months 3.92% Over 6 Months -17.75% Over 1 Year -44.11%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    LYKA LABS LTD fundamentals


    • Market cap (Cr) 216.60
    • P/E Ratio (TTM) -6.94
    • Beta 1.18
    • Book Value / share 24.19
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -29.77
    info icon alternate text
    • Market cap (Cr) 216.90
    • P/E Ratio (TTM) -6.94
    • Beta 1.06
    • Book Value / share 24.19
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -29.77
    info icon alternate text

    LYKA LABS LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 28.03
    Operating Expense 35.43
    Net Profit -29.77
    Net Profit Margin (%) -106.20
    Earnings Per Share (EPS) -8.34
    EBITDA -26.99
    Effective Tax Rate (%) 0.43
    Particulars DEC 2025 (Values in Cr)
    Revenue 30.73
    Operating Expense 31.81
    Net Profit 0.29
    Net Profit Margin (%) 0.94
    Earnings Per Share (EPS) 0.08
    EBITDA 3.26
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 32.97
    Operating Expense 38.99
    Net Profit -3.63
    Net Profit Margin (%) -11.01
    Earnings Per Share (EPS) -1.02
    EBITDA -1.94
    Effective Tax Rate (%) 24.37
    Particulars JUN 2025 (Values in Cr)
    Revenue 29.18
    Operating Expense 28.67
    Net Profit 0.81
    Net Profit Margin (%) 2.77
    Earnings Per Share (EPS) 0.22
    EBITDA 4.05
    Effective Tax Rate (%) 30.76
    Particulars MAR 2025 (Values in Cr)
    Revenue 30.52
    Operating Expense 29.16
    Net Profit 1.23
    Net Profit Margin (%) 4.03
    Earnings Per Share (EPS) 0.36
    EBITDA 4.12
    Effective Tax Rate (%) 43.57
    Particulars MAR 2026 (Values in Cr)
    Revenue 120.91
    Operating Expense 135.10
    Net Profit -32.29
    Net Profit Margin (%) -26.70
    Earnings Per Share (EPS) -9.05
    EBITDA -21.45
    Effective Tax Rate (%) 2.85
    Particulars MAR 2025 (Values in Cr)
    Revenue 134.70
    Operating Expense 126.35
    Net Profit 7.92
    Net Profit Margin (%) 5.87
    Earnings Per Share (EPS) 2.28
    EBITDA 20.16
    Effective Tax Rate (%) 28.64
    Particulars MAR 2024 (Values in Cr)
    Revenue 106.40
    Operating Expense 108.92
    Net Profit -2.27
    Net Profit Margin (%) -2.13
    Earnings Per Share (EPS) -0.72
    EBITDA 16.16
    Effective Tax Rate (%) -144.08
    Particulars MAR 2023 (Values in Cr)
    Revenue 80.59
    Operating Expense 90.08
    Net Profit -13.29
    Net Profit Margin (%) -16.49
    Earnings Per Share (EPS) -4.65
    EBITDA 11.87
    Effective Tax Rate (%) -0.60
    Particulars MAR 2022 (Values in Cr)
    Revenue 164.35
    Operating Expense 102.16
    Net Profit 39.90
    Net Profit Margin (%) 24.27
    Earnings Per Share (EPS) 13.87
    EBITDA 95.55
    Effective Tax Rate (%) 33.76
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 25.89
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.44
    EBITDA Margin 0.01
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 29.35
    ROE % 5.25
    ROCE % 6.62
    Total Debt to Total Equity 0.55
    EBITDA Margin 14.56
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 17.86
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.14
    EBITDA Margin 15.44
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 9.12
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 3.36
    EBITDA Margin 21.75
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 4.65
    ROE % 77.59
    ROCE % 40.57
    Total Debt to Total Equity 0.00
    EBITDA Margin 53.20
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 24.38
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.42
    EBITDA Margin 1.29
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 34.07
    ROE % 4.75
    ROCE % 6.15
    Total Debt to Total Equity 0.43
    EBITDA Margin 14.97
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 27.28
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.73
    EBITDA Margin 15.18
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 19.22
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.64
    EBITDA Margin 23.64
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 15.49
    ROE % 58.27
    ROCE % 35.98
    Total Debt to Total Equity 5.77
    EBITDA Margin 58.14
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 1.35
    Total Assets 174.53
    Total Liabilities 174.53
    Total Equity 90.83
    Share Outstanding 3
    Price to Book Ratio 1.84
    Return on Assets (%) -5.74
    Return on Capital (%) -7.21
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.34
    Total Assets 176.20
    Total Liabilities 176.20
    Total Equity 103.58
    Share Outstanding 3
    Price to Book Ratio 2.96
    Return on Assets (%) 4.54
    Return on Capital (%) 5.66
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 5.94
    Total Assets 156.72
    Total Liabilities 156.72
    Total Equity 68.26
    Share Outstanding 3
    Price to Book Ratio 3.88
    Return on Assets (%) -1.58
    Return on Capital (%) -1.99
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 11.71
    Total Assets 151.52
    Total Liabilities 151.52
    Total Equity 45.67
    Share Outstanding 3
    Price to Book Ratio 5.45
    Return on Assets (%) -8.71
    Return on Capital (%) -11.26
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 17.05
    Total Assets 185.61
    Total Liabilities 185.61
    Total Equity 13.49
    Share Outstanding 2
    Price to Book Ratio 8.75
    Return on Assets (%) 21.01
    Return on Capital (%) 27.25
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 1.18
    Total Assets 170.74
    Total Liabilities 170.74
    Total Equity 86.99
    Share Outstanding 3
    Price to Book Ratio 1.84
    Return on Assets (%) -18.91
    Return on Capital (%) -23.85
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.32
    Total Assets 192.68
    Total Liabilities 192.68
    Total Equity 121.60
    Share Outstanding 3
    Price to Book Ratio 2.96
    Return on Assets (%) 4.10
    Return on Capital (%) 4.96
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 5.88
    Total Assets 186.01
    Total Liabilities 186.01
    Total Equity 99.32
    Share Outstanding 3
    Price to Book Ratio 3.88
    Return on Assets (%) -1.21
    Return on Capital (%) -1.46
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 8.69
    Total Assets 178.85
    Total Liabilities 178.85
    Total Equity 76.42
    Share Outstanding 3
    Price to Book Ratio 5.45
    Return on Assets (%) -7.42
    Return on Capital (%) -9.01
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 15.38
    Total Assets 208.51
    Total Liabilities 208.51
    Total Equity 44.43
    Share Outstanding 2
    Price to Book Ratio 8.75
    Return on Assets (%) 19.13
    Return on Capital (%) 23.11
    Particulars MAR 2026 (Values in Cr)
    Net Income -11.77
    Cash from Operations 5.54
    Cash from Investing -9.41
    Cash from Financing 4.18
    Net change in Cash 0.01
    Free Cash Flow 16.67
    Particulars MAR 2025 (Values in Cr)
    Net Income 11.12
    Cash from Operations 4.93
    Cash from Investing -11.79
    Cash from Financing 5.29
    Net change in Cash -4.60
    Free Cash Flow 20.58
    Particulars MAR 2024 (Values in Cr)
    Net Income -0.93
    Cash from Operations 3.29
    Cash from Investing -9.48
    Cash from Financing 1.95
    Net change in Cash -5.76
    Free Cash Flow 12.52
    Particulars MAR 2023 (Values in Cr)
    Net Income -13.17
    Cash from Operations 8.74
    Cash from Investing 7.35
    Cash from Financing -21.64
    Net change in Cash -5.33
    Free Cash Flow 16.93
    Particulars MAR 2022 (Values in Cr)
    Net Income 59.24
    Cash from Operations 80.16
    Cash from Investing -6.17
    Cash from Financing -63.17
    Net change in Cash 9.89
    Free Cash Flow 87.67
    Particulars MAR 2026 (Values in Cr)
    Net Income -33.23
    Cash from Operations 5.56
    Cash from Investing -9.42
    Cash from Financing 4.19
    Net change in Cash -0.14
    Free Cash Flow 16.69
    Particulars MAR 2025 (Values in Cr)
    Net Income 11.10
    Cash from Operations 1.41
    Cash from Investing -11.21
    Cash from Financing 8.24
    Net change in Cash -4.58
    Free Cash Flow 17.07
    Particulars MAR 2024 (Values in Cr)
    Net Income -0.93
    Cash from Operations 4.55
    Cash from Investing -8.60
    Cash from Financing 2.70
    Net change in Cash -2.80
    Free Cash Flow 13.79
    Particulars MAR 2023 (Values in Cr)
    Net Income -13.20
    Cash from Operations 7.28
    Cash from Investing 6.76
    Cash from Financing -20.32
    Net change in Cash -6.68
    Free Cash Flow 16.11
    Particulars MAR 2022 (Values in Cr)
    Net Income 60.24
    Cash from Operations 77.08
    Cash from Investing -4.32
    Cash from Financing -63.35
    Net change in Cash 8.85
    Free Cash Flow 83.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.06 12.89 1.50 238.02 23.12 38.85
    BLISS GVS PHARMA LTD. 450.40 36.21 4.00 4776.77 118.35 552.90
    CIPLA LTD 1444.65 32.61 3.38 116705.37 1165.55 1672.20
    FERMENTA BIOTECH LTD. 456.25 21.34 3.30 1342.79 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.06 21.72 4.00 238.02 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 511.40 22.92 3.99 1478.49 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8069.50 105.46 23.11 20173.75 7630.00 9850.00
    BLISS GVS PHARMA LTD. 450.40 48.69 4.13 4776.77 118.35 552.90

    LYKA LABS LTD shareholding pattern

    Holding
    40.72%
    58.45%
    0.16%
    0.65%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    LYKA LABS LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    59.90 -2.93 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 63.70
    • 26 Days 67.10
    • 10 Days 65.30
    • 50 Days 66.40
    • 12 Days 65.80
    • 100 Days 66.70
    • 20 Days 66.90
    • 200 Days 74.00
    63.03 PIVOT
    First Support 59.87 First Resistance 64.88 Second Support 58.02 Second Resistance 68.04 Third Support 54.86 Third Resistance 69.89
    RSI 35.71 ADX 31.48 MACD -1.28 Williams % R -89.63 Commodity Channel Index (CCI) -141.06
    Date 2026-07-01 Week 41110.00 Same Day 55102.00 Month 53763.00
    1 Year 1.19 3 Year 1.03
    Over 1 Month
    -15.51% down
    Over 1 Year
    -44.11% down
    Over 3 Months
    3.92% down
    Over 3 Years
    -17.79% down
    Over 6 Months
    -17.75% down
    Over 5 Years
    -3.10% down

    LYKA LABS LTD Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Lyka Labs Ltd?

    Answer Field

    Lyka Labs Ltd share price is for NSE ₹ 60.00 & for BSE ₹ 61.98 as on Jul 29 2026 11:39 AM.

    What is the Market Cap of Lyka Labs Ltd Share?

    Answer Field

    The market cap of Lyka Labs Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 29 2026 11:39 AM.

    What is the 52 Week High and Low of Lyka Labs Ltd?

    Answer Field

    The 52 Week High and Low of Lyka Labs Ltd for NSE is ₹ 121.44 and ₹ 44.10 and for BSE is ₹ 121.00 and ₹ 44.49.

    What is 1 year return for Lyka Labs Ltd?

    Answer Field

    The 1 year returns on the stock has been -44.11%.

    What is the P/E Ratio of Lyka Labs Ltd Share?

    Answer Field

    As on Jul 29 2026 11:39 AM the price-to-earnings (PE) ratio for Lyka Labs Ltd share is -6.94.

    What is the PB ratio of Lyka Labs Ltd Share?

    Answer Field

    As on Jul 29 2026 11:39 AM, the price-to-book (PB) ratio for Lyka Labs Ltd share is 24.19.

    How to Buy Lyka Labs Ltd Share?

    Answer Field

    You can trade in Lyka Labs Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Lyka Labs Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Lyka Labs Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Lyka Labs Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |